🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Weiwei Tan

Pfizer (United States)

ORCID: 0000-0001-8915-1152
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer”.

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-23912-4
N/A
1.1DataRank · unranked
34 citations

Adam J. Schoenfeld, Alex Makhnin, Yosef Y. Tobi, Yuli Wang, Heidie Frisco Cabanos +10 more